200
Participants
Start Date
February 26, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
August 1, 2027
OKI-219
Oral twice daily
Fulvestrant
Intramuscular injection
Trastuzumab
Intravenous (IV)
Tucatinib
Oral twice daily
Atirmociclib
Oral twice daily
Ribociclib
Oral once daily continuous for 21-days followed by 7 days off
RECRUITING
Institut Jules Bordet, Anderlecht
RECRUITING
GZA Hopsitals Campus Sint-Augustinus, Wilrijk
RECRUITING
UZ Leuven - Campus Gasthuisberg, Leuven
RECRUITING
Stony Brook University, Stony Brook
RECRUITING
Istituto Clinico Humanitas, Rozzano
RECRUITING
Ospedale San Raffaele, Milan
RECRUITING
Ospedale San Gerardo-ASST Monza, Monza
RECRUITING
Centre de Lutte Contre le Cancer CLCC - Centre Georges Francois Leclerc (CGFL), Dijon
RECRUITING
Gachon University Gil Medical Center, Incheon
RECRUITING
NEXT Oncology Virginia, Fairfax
RECRUITING
Hospital Beata Maria Ana, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
START - Madrid, Madrid
RECRUITING
SCRI Oncology Partners - Nashville, Nashville
WITHDRAWN
Karmanos Cancer Insitute, Detroit
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Hopital Lyon Sud, Pierre-Bénite
RECRUITING
Regents of the University of Colorado, Aurora
RECRUITING
Sarah Cannon Research Institute at HealthONE, Denver
RECRUITING
Comprehensive Cancer Centers of Nevada, Las Vegas
RECRUITING
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
RECRUITING
California Cancer Associates for Research and Excellence, Encinitas
RECRUITING
University of California San Diego UCSD, La Jolla
RECRUITING
Hoag - Huntington Beach, Newport Beach
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
Fred Hutchinson Cancer Center, Seattle
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Centre Antoine Lacassagne, Nice
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Seoul
RECRUITING
Asan Medical Center, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
NEXT Oncology Phase I Unit / IOB- Hospital Quironsalud Barcelona, Barcelona
OnKure, Inc.
INDUSTRY